Doctors Look to Existing Drugs in Coronavirus Fight
More than two dozen studies are under way or planned to test everything from traditional Chinese medicine to vitamin C, stem cells, steroids, and to medications developed to fight other viruses, like the flu and HIV.
One would hope that it does not require an ongoing pandemic and related hysteria to point out that old people have poorly functioning immune systems, and thus suffer disproportionately the burden of infectious disease. But perhaps it does. The 2017-2018 seasonal influenza, a modestly more severe occurrence of something that happens every year, killed something like 60,000 people in the US alone, with little notice or comment. There is nothing so terrible that it won't be accepted - ignored, even - if it is normal. Floodgates of funding for infectious disease research and development have been opened in response to C...
By CHADI NABHAN MD, MBA, FACP One harsh Chicago winter, I remember calling a patient to cancel his appointment because we had deemed it too risky for patients to come in for routine visits—a major snowstorm made us rethink all non-essential appointments. Mr. Z was scheduled for his 3-month follow-up for an aggressive brain lymphoma that was diagnosed the prior year, during which he endured several rounds of intense chemotherapy. His discontent in hearing that his appointment was canceled was palpable; he confessed that he was very much looking forward to the visit so that he could greet the nurses, front-desk sta...
The treatment, which has been promoted by President Trump ’s personal lawyer, Rudy Giuliani, will begin early-stage clinical trials.
Immunotherapy startup Celuarity announced the FDA has cleared its application for an investigational new stem-cell therapy against COVID-19.
Immunotherapy startup Celuarity announced the FDA has cleared its application for an investigational new stem cell therapy against COVID-19.
Having trouble viewing this email? View it as a Web page. NIDCR's Spring 2020 E-Newsletter In this issue: NIDCR News Funding Opportunities NIH/HHS News Funding Notices Science Advances Subscribe to NICDR News Grantee News NIDCR News CDC’s COVID-19 Guidance for Dental Settings Dental health care personnel can find COVID-19-related information on the CDC’s Division of Oral Health website, which offers guidance and resources for clinics and health care facilities and recommen...
Condition: COVID-19 Intervention: Biological: Dental pulp mesenchymal stem cells Sponsor: CAR-T (Shanghai) Biotechnology Co., Ltd. Not yet recruiting
Condition: Severe Acute Respiratory Syndrome (SARS) Pneumonia Intervention: Combination Product: Stem Cell Educator-Treated Mononuclear Cells Apheresis Sponsors: Tianhe Stem Cell Biotechnologies Inc.; Hackensack Meridian Health Not yet recruiting